A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat

被引：10

作者：

Carreras-Badosa, Gemma ^{[1
]}

Gomez-Vilarrubla, Ariadna ^{[2
]}

Mas-Pares, Berta ^{[1
]}

Martinez-Calcerrada, Jose-Maria ^{[2
]}

Xargay-Torrent, Silvia ^{[1
]}

Prats-Puig, Anna ^{[3
]}

Puerto-Carranza, Elsa ^{[1
,4
]}

Diaz-Roldan, Ferran ^{[1
]}

de Zegher, Francis ^{[5
]}

Ibanez, Lourdes ^{[6
,7
]}

Bassols, Judit ^{[2
]}

Lopez-Bermejo, Abel ^{[1
,4
,8
]}

机构：

[1] Girona Biomed Res Inst, Pediat Endocrinol Grp, Girona, Spain

[2] Girona Biomed Res Inst, Maternal Fetal Metab Grp, Girona, Spain

[3] Univ Girona, Univ Sch Hlth & Sport EUSES, Girona, Spain

[4] Dr Josep Trueta Hosp, Pediat, Girona, Spain

[5] Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium

[6] Univ Barcelona, St Joan Deu Childrens Hosp, Pediat Inst, Barcelona, Spain

[7] Inst Salud Carlos III, CIBERDEM, Madrid, Spain

[8] Univ Girona, Dept Med Sci, Girona, Spain

来源：

PEDIATRIC OBESITY | 2022年 / 17卷 / 02期

关键词：

GDF-15; metformin; obesity; visceral fat; weight loss;

D O I：

10.1111/ijpo.12845

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Background Metformin treatment for 24 months in children with obesity lowers body mass index (BMI), reduces liver fat, and normalizes endocrine-metabolic parameters. Objective Here we study whether circulating GDF-15 levels were raised by such metformin treatment and whether they related to changes in body weight and visceral fat in children with obesity. Methods The study population consisted of 18 pre-pubertal/early pubertal children with obesity who had participated in a randomized double-blind clinical trial receiving metformin (850 mg/day) or placebo for 24 months. Circulating GDF-15, BMI and abdominal visceral and liver fat (magnetic resonance imaging) were assessed at 0, 6, 12 and 24 months. Results Results showed that metformin-treated children had higher GDF-15 levels at 6 and 12 months. Higher rises of circulating GDF-15 associated with more loss of body weight and visceral fat. Conclusion In conclusion, the concept that GDF-15 is among the mediators of metformin's normalizing effects in individuals with obesity is herewith extended into childhood.

引用

页数：5

共 19 条

[1]

[Anonymous], 2008, ENDOCRINOLOGIA NUTR, DOI DOI 10.1016/S1575-0922(08)75845-5

[2] Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion [J].

August, Gilbert P. ;

Caprio, Sonia ;

Fennoy, Ilene ;

Freemark, Michael ;

Kaufman, Francine R. ;

Lustig, Robert H. ;

Silverstein, Janet H. ;

Speiser, Phyllis W. ;

Styne, Dennis M. ;

Montori, Victor M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (12) :4576-4599

[3] Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study [J].

Bassols, Judit ;

Martinez-Calcerrada, Jose-Maria ;

Osiniri, Ines ;

Diaz-Roldan, Ferran ;

Xargay-Torrent, Silvia ;

Mas-Pares, Berta ;

Dorado-Ceballos, Estefania ;

Prats-Puig, Anna ;

Carreras-Badosa, Gemma ;

de Zegher, Francis ;

Ibanez, Lourdes ;

Lopez-Bermejo, Abel .

PLOS ONE, 2019, 14 (12)

[4] Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance [J].

Burgert, Tania S. ;

Duran, Elvira J. ;

Goldberg-Gell, Rachel ;

Dziura, James ;

Yeckel, Catherine W. ;

Katz, Stuart ;

Tamborlane, William V. ;

Caprio, Sonia .

PEDIATRIC DIABETES, 2008, 9 (06) :567-576

[5]

Clarson Cheril L, 2014, Int Sch Res Notices, V2014, P659410, DOI 10.1155/2014/659410

[6] GDF15 mediates the effects of metformin on body weight and energy balance [J].

Coll, Anthony P. ;

Chen, Michael ;

Taskar, Pranali ;

Rimmington, Debra ;

Patel, Satish ;

Tadross, John A. ;

Cimino, Irene ;

Yang, Ming ;

Welsh, Paul ;

Virtue, Samuel ;

Goldspink, Deborah A. ;

Miedzybrodzka, Emily L. ;

Konopka, Adam R. ;

Esponda, Raul Ruiz ;

Huang, Jeffrey T. -J. ;

Tung, Y. C. Loraine ;

Rodriguez-Cuenca, Sergio ;

Tomaz, Rute A. ;

Harding, Heather P. ;

Melvin, Audrey ;

Yeo, Giles S. H. ;

Preiss, David ;

Vidal-Puig, Antonio ;

Vallier, Ludovic ;

Nair, K. Sreekumaran ;

Wareham, Nicholas J. ;

Ron, David ;

Gribble, Fiona M. ;

Reimann, Frank ;

Sattar, Naveed ;

Savage, David B. ;

Allan, Bernard B. ;

O'Rahilly, Stephen .

NATURE, 2020, 578 (7795) :444-+

[7] Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss [J].

Day, Emily A. ;

Ford, Rebecca J. ;

Smith, Brennan K. ;

Mohammadi-Shemirani, Pedrum ;

Morrow, Marisa R. ;

Gutgesell, Robert M. ;

Lu, Rachel ;

Raphenya, Amogelang R. ;

Kabiri, Mostafa ;

McArthur, Andrew G. ;

McInnes, Natalia ;

Hess, Sibylle ;

Pare, Guillaume ;

Gerstein, Hertzel C. ;

Steinberg, Gregory R. .

NATURE METABOLISM, 2019, 1 (12) :1202-+

[8]

Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]

[9] The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes [J].

Freemark, M ;

Bursey, D .

PEDIATRICS, 2001, 107 (04) :E55

[10] Growth Differentiation Factor 15 as a Novel Biomarker for Metformin [J].

Gerstein, Hertzel C. ;

Pare, Guillaume ;

Hess, Sibylle ;

Ford, Rebecca J. ;

Sjaarda, Jennifer ;

Raman, Kripa ;

McQueen, Matthew ;

Lee, ShunFu ;

Haenel, Heinz ;

Steinberg, Gregory R. .

DIABETES CARE, 2017, 40 (02) :280-283

← 1 2 →